Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hologic teams with iCAD

This article was originally published in The Gray Sheet

Executive Summary

Firms target low-volume, film-based mammography clinics under a private label distribution pact in which iCAD will make film-based computer-aided detection (CAD) systems for Hologic to combine with its film-based, analog mammography systems. Hologic estimates that lower-volume centers account for over half the market for breast cancer analog CAD products. In September, iCAD gained PMA supplement approval to use its Second Look Digital CAD software with Hologic's Selenia full-field digital mammography system (1"The Gray Sheet" Sept. 20, 2004, In Brief)...

You may also be interested in...



iCAD adds Hologic compatibility

iCAD gains PMA supplement approval for use of its Second Look digital computer-aided detection software with Hologic's Selenia full-field digital mammography (FFDM) system. The approval brings iCAD even with competitor R2 as a provider of CAD for all FDA-approved FFDM systems, including those offered by Hologic, Siemens, GE Healthcare and Fisher...

Biogen Doubles Down On Alzheimer’s and Neuroscience With Sangamo Gene Regulation Deal

As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.

C-Suite Snippets: Growth Of A Cell And Gene Powerhouse

In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.

UsernamePublicRestriction

Register

MT021233

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel